BioForce Nanosciences Holdings, Inc.
BFNH
$0.8004
-$0.0062-0.77%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.98% | 4.32% | 3.92% | 1.99% | -1.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.98% | 4.32% | 3.92% | 1.99% | -1.66% |
| Operating Income | -5.98% | -4.32% | -3.92% | -1.99% | 1.66% |
| Income Before Tax | -175.30% | -173.81% | -3.92% | -1.99% | 1.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -175.30% | -173.81% | -3.92% | -1.99% | 1.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -175.30% | -173.81% | -3.92% | -1.99% | 1.66% |
| EBIT | -5.98% | -4.32% | -3.92% | -1.99% | 1.66% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -153.70% | -154.94% | -4.35% | -2.48% | 1.22% |
| Normalized Basic EPS | -1.00% | -2.00% | -4.00% | -2.00% | 1.96% |
| EPS Diluted | -153.70% | -154.94% | -4.35% | 25.68% | 28.00% |
| Normalized Diluted EPS | -1.00% | -2.00% | -4.00% | -2.00% | 1.96% |
| Average Basic Shares Outstanding | 6.17% | 2.54% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 6.17% | 2.54% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |